午盘收盘，国内期货主力合约涨跌互现，鸡蛋跌近5%，沪银跌超4%，铂跌超3%，液化石油气（LPG）、丙烯、聚丙烯、沪金跌近3%。涨幅方面，合成橡胶、铸造铝合金、20号胶涨超1%，乙二醇（EG）、沪铝、沪锡涨近1%。

FTSE China A50 index futures opened 0.18% higher.

China's National Medical Products Administration approved Eli Lilly Nederland B.V.'s class-1 innovative drug elacestrant tosylate tablets (brand INLURIYO) for adults with locally advanced or metastatic estrogen receptor–positive (ER+), HER2–negative, ESR1‑mutant breast cancer previously treated with endocrine therapy. Approval covers use as monotherapy and in combination with abemaciclib for the same population, giving Eli Lilly market access in China for an endocrine‑therapy–resistant ER+/HER2– indication.